RARITAN, N.J., June 7, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO ...
RARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO ...
The revolutionary ORTHO VISION® analyzer is a highly interactive, fully automated blood bank analyzer engineered for the specific needs of transfusion medicine. Utilizing innovative ID-MTS ® gel ...
RARITAN, NJ--(Marketwired - Oct 14, 2015) - Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received ...
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO VISION ® Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, ...
RARITAN, NJ--(Marketwired - Nov 12, 2015) - Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer, a ...
Please provide your email address to receive an email when new articles are posted on . Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer ...
RARITAN, N.J., Nov. 30, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results